Zobrazeno 1 - 10
of 11 212
pro vyhledávání: '"Haller J."'
Autor:
Kaitlyn Dinkins, Wade Barton, Lauren Wheeler, Haller J. Smith, Karthikeyan Mythreye, Rebecca C. Arend
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101450- (2024)
Ovarian cancer continues to have a high mortality rate despite therapeutic advances. Traditionally, treatment has focused on surgery followed by systemic platinum- based chemotherapy. Unfortunately, most patients develop resistance to platinum agents
Externí odkaz:
https://doaj.org/article/41c241c9f607491c9666954579f8b250
Autor:
Kaitlyn Kincaid, Teresa K.L. Boitano, Matthew Scalise, Samantha Patton, Charles A. Leath, III, John M. Straughn, Jr., Haller J. Smith
Publikováno v:
Gynecologic Oncology Reports, Vol 52, Iss , Pp 101344- (2024)
Objective: We aimed to assess the impact of preoperative steroid administration and perioperative glycemic control on postoperative complications in diabetic gynecologic oncology patients undergoing laparotomy. Methods: This retrospective cohort stud
Externí odkaz:
https://doaj.org/article/20702e923d824d749d9a05b3d01abe48
Autor:
Tyler R. McCaw, Nidhi Goel, Dewey J. Brooke, Ashwini A. Katre, Angelina I. Londoño, Haller J. Smith, Troy D. Randall, Rebecca C. Arend
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 709-717 (2021)
Abstract Objective Patients with epithelial ovarian cancer (EOC) typically present with late‐stage disease, posing a significant challenge to treatment. Although taxane and platinum‐based chemotherapy plus surgical debulking are initially effecti
Externí odkaz:
https://doaj.org/article/83df489cacd3490e906c5b849f504716
Publikováno v:
Gynecologic Oncology Reports, Vol 29, Iss , Pp 123-125 (2019)
Poly-ADP ribose polymerase inhibitors (PARPi) are a promising new treatment option for patients with ovarian cancer and are moderately emetogenic. Tolerance of therapy is paramount, and uncontrolled nausea and vomiting may limit use. Although most pa
Externí odkaz:
https://doaj.org/article/928dd2fbe16d473fa5e4e4363687c29a
Publikováno v:
Gynecologic Oncology Reports, Vol 20, Iss C, Pp 81-86 (2017)
Despite a good initial response to chemotherapy, the majority of patients with epithelial ovarian cancer will eventually recur and die of their disease. The introduction of targeted therapies to traditional chemotherapy regimens has done little to im
Externí odkaz:
https://doaj.org/article/09090ab521904de9b58e1bc89bcc1ca5
Publikováno v:
Gynecologic Oncology Reports, Vol 21, Iss C, Pp 17-19 (2017)
Externí odkaz:
https://doaj.org/article/33b488034a7e47a7858e8c7825fbd842
Autor:
Dinkins, Kaitlyn, Barton, Wade, Wheeler, Lauren, Smith, Haller J., Mythreye, Karthikeyan, Arend, Rebecca C.
Publikováno v:
In Gynecologic Oncology Reports August 2024 54
Autor:
Kincaid, Kaitlyn, Boitano, Teresa K.L., Scalise, Matthew, Patton, Samantha, Leath, Charles A., III, Straughn, John M., Jr., Smith, Haller J.
Publikováno v:
In Gynecologic Oncology Reports April 2024 52
Autor:
Boitano, Teresa K.L., Gardner, Austin, Chu, Daniel I., Leath, Charles A., III, Straughn, J. Michael, Jr, Smith, Haller J.
Publikováno v:
In Gynecologic Oncology November 2023 178:23-26